Latest filing published 24 Jul 2026 for Rapid Micro Biosystems, INC., €922. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Robert G. Spignesi Jr. in Rapid Micro Biosystems, Inc., where the filings describe the role as chief executive. Between 11 February 2022 and 22 July 2026, the trades on record add up to 24 filings.
In open-market terms, that means 5 purchases worth €118k on one side and 3 sales worth €231k on the other. On balance, insiders were net sellers of €113k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 11 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The median purchase comes to €29k. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 24 July 2026, the filings show an option exercise worth €922 in Rapid Micro Biosystems, Inc. The last purchase on record was published on 7 August 2024, which is 805 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations